TY - JOUR
KW - Adolescent
KW - Adult
KW - Age Factors
KW - Buprenorphine/therapeutic use
KW - Cross-Sectional Studies
KW - Female
KW - Humans
KW - Insurance Coverage
KW - Male
KW - Middle Aged
KW - Narcotic Antagonists/therapeutic use
KW - Opioid-Related Disorders/drug therapy
KW - Socioeconomic Factors
KW - Young Adult
AU - T. R. Rieckmann
AU - N. Gideonse
AU - A. Risser
AU - J. E. DeVoe
AU - A. J. Abraham
A1 - 
AB - Research has examined the safety, efficacy, feasibility, and cost-effectiveness of buprenorphine for the treatment of opioid dependence, but few studies have examined patient and provider experiences, especially in community health centers. Using de-identified electronic health record system (EHRS) data from 70 OCHIN community health centers (n = 1825), this cross-sectional analysis compared the demographics, comorbidities, and service utilization of patients receiving buprenorphine to those not receiving medication-assisted treatment (MAT). Compared to non-MAT patients, buprenorphine patients were younger and less likely to be Hispanic or live in poverty. Buprenorphine patients were less likely to have Medicaid insurance coverage, more likely to self-pay, and have private insurance coverage. Buprenorphine patients were less likely to have problem medical comorbidities or be coprescribed high-risk medications. It is important for providers, clinic administrators, and patients to understand the clinical application of medications for opioid dependence to ensure safe and effective care within safety net clinics.
AD - OHSU-PSU School of Public Health, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, 97239-3098, USA. rieckman@ohsu.edu.; Department of Family Medicine, Oregon Health & Science University, Portland, OR, 97239-3098, USA.; Department of Family Medicine, Oregon Health & Science University, Portland, OR, 97239-3098, USA.; OCHIN Community Health Information Network, Portland, OR, 97201-5195, USA.; Department of Public Administration and Policy, University of Georgia, Athens, GA, 30602, USA.
BT - The journal of behavioral health services & research
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 3
CY - United States
DO - 10.1007/s11414-017-9553-z
IS - 3
JF - The journal of behavioral health services & research
M1 - Journal Article
N2 - Research has examined the safety, efficacy, feasibility, and cost-effectiveness of buprenorphine for the treatment of opioid dependence, but few studies have examined patient and provider experiences, especially in community health centers. Using de-identified electronic health record system (EHRS) data from 70 OCHIN community health centers (n = 1825), this cross-sectional analysis compared the demographics, comorbidities, and service utilization of patients receiving buprenorphine to those not receiving medication-assisted treatment (MAT). Compared to non-MAT patients, buprenorphine patients were younger and less likely to be Hispanic or live in poverty. Buprenorphine patients were less likely to have Medicaid insurance coverage, more likely to self-pay, and have private insurance coverage. Buprenorphine patients were less likely to have problem medical comorbidities or be coprescribed high-risk medications. It is important for providers, clinic administrators, and patients to understand the clinical application of medications for opioid dependence to ensure safe and effective care within safety net clinics.
PP - United States
PY - 2017
SN - 1556-3308; 1094-3412
SP - 351
EP - 363
EP - 
T1 - Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data
T2 - The journal of behavioral health services & research
TI - Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 28488155
U3 - 10.1007/s11414-017-9553-z
VL - 44
VO - 1556-3308; 1094-3412
Y1 - 2017
Y2 - Jul
ER -